Product
Supplier
Encyclopedia
Inquiry
Fluralaner864731-61-3 buy - large image1
Fluralaner864731-61-3 buy - image1
Fluralaner864731-61-3 buy - image2
Fluralaner864731-61-3 buy - image3
Fluralaner864731-61-3 buy - image4
Fluralaner864731-61-3 buy - image5
Fluralaner864731-61-3 buy - image6

Fluralaner864731-61-3

35 Inquiries

Unit Price:

$33-34/MT FOB

Get Latest Price
CAS No.:

864731-61-3

Grade:

Pharmaceutical Grade

Content:

99.5%

Port:

shanghai

Brand:

OORENT

Packaging:

Vial/Bottle/Bag/Carton

Sample Available:

Yes

Price valid (until):

2026-11-12

Company Type:
Trader
Location:
China
Payment Terms:
100% TT in advance
Average Lead Time:
10 days
Qualification:
Main Products:

pharmaceutical intermediates,peptides,electronic chemicals

  • Product Description

  • Seller Information

  • Inquiry History

  • Description

    Product Detailv

    Fluralaner Basic information
    Product Name: Fluralaner
    Synonyms: Fluralaner;A1443; AH252723;AH252723;Fluralaner-012;Fluralaner (A1443;Frellana;Fluralaner D2Q: What is Fluralaner D2 Q: What is the CAS Number of Fluralaner D2;Fluralaner D3Q: What is Fluralaner D3 Q: What is the CAS Number of Fluralaner D3
    CAS: 864731-61-3
    MF: C22H17Cl2F6N3O3
    MW: 556.29
    EINECS: 200-001-8
    Product Categories: 1;API;864731-61-3
    Mol File: 864731-61-3.mol
    Shop Fluralaner864731-61-3-Detailed Image 1

    Fluralaner Chemical Properties
    density  1.51±0.1 g/cm3(Predicted)
    storage temp.  Store at -20°C
    solubility  DMSO:150.0(Max Conc. mg/mL);269.65(Max Conc. mM)
    Ethanol:25.0(Max Conc. mg/mL);44.94(Max Conc. mM)
    pka 12.50±0.46(Predicted)
    form  A crystalline solid
    color  White to off-white
    InChIKey MLBZKOGAMRTSKP-UHFFFAOYSA-N
    SMILES C(NCC(=O)NCC(F)(F)F)(=O)C1=CC=C(C2CC(C3=CC(Cl)=CC(Cl)=C3)(C(F)(F)F)ON=2)C=C1C

    Safety Information
    MSDS Information


    Fluralaner Usage And Synthesis
    Description Fluralaner (INN) is a systemic insecticide and acaricide that is administered orally. The U.S. Food and Drug Administration (FDA) approved it under the trade name Bravecto for flea treatment in dogs in May 2014. The EU approved the drug in February 2014. Australia approved it for the treatment and prevention of ticks and fleas on dogs in January 2015.
    Uses Fluralaner(864731-61-3) is a novel systemically administered insecticidal and acaricidal compound that provides long-acting efficacy after oral administration to dogs. Fluralaner belongs to a new class of compounds, the isoxazolines. A field study has shown that a single fluralaner dose administered orally to dogs provides at least twelve weeks of flea- and tick-control. The long duration of activity offers a more convenient treatment over monthly flea and tick control treatments with a potential compliance advantage, reducing the risk of vector-transmitted diseases.
    Indications Fluralaner is an insecticide and acaricide used to treat Sarcoptes scabiei var. canis infestation in dogs. Flea treatment. A possible anti-malarial found to kill disease-spreading mosquitoes when they bite treated people.
    Pharmacokinetics Following oral administration, fluralaner is readily absorbed reaching maximum plasma concentrations within 1 day. Food enhances the absorption. Fluralaner is systemically distributed and reaches the highest concentrations in fat, followed by liver, kidney and muscle. The prolonged persistence and slow elimination from plasma (t1/2 = 12 days) and the lack of extensive metabolism provide effective concentrations of fluralaner for the duration of the inter-dosing interval. Individual variation in Cmax and t1/2 was observed. The major route of elimination is the excretion of unchanged fluralaner in faeces (~90% of the dose). Renal clearance is the minor route of elimination.
    Side effects Most pets have very few side effects from fluralaner, provided it is given according to label recommendations and at the prescribed interval (or for off-label use, according to your veterinarian's directions). Side effects may include vomiting, diarrhea, decreased appetite, or flaky skin.
    vcahospitals.com
    Synthesis The synthesis of fluralaner is mainly obtained by the reaction of the intermediates 4-(5-(3,5-dichlorophenyl)-5-trifluoromethyl-4,5-dihydroisoazol-3-yl)-2-methylbenzoic acid (Intermediate I) and 2-amino-N-(2,2,2-trifluoroethyl)acetamide (Intermediate II).
    Overdosage No adverse reactions were observed following oral administration to puppies aged 8–9 weeks and weighing 2.0–3.6 kg treated with overdoses of up to 5 times the maximum recommended dose (56 mg, 168 mg and 280 mg fluralaner/kg bodyweight) on three occasions at shorter intervals than recommended (8-week intervals).
    There were no findings on reproductive performance and no findings of concern on offspring viability when fluralaner was administered orally to Beagle dogs at overdoses of up to 3 times the maximum recommended dose (up to 168 mg/kg bodyweight of fluralaner).
    The veterinary medicinal product was well tolerated in Collies with a deficient multidrug-resistanceprotein 1 (MDR1 -/-) following single oral administration at 3 times the recommended dose (168 mg/kg bodyweight). No treatment-related clinical signs were observed.
    Drug interactions Fluralaner is highly bound to plasma proteins and might compete with other highly bound drugs such as non-steroidal anti-inflammatory drugs (NSAIDs) and the cumarin derivative warfarin. Incubation of fluralaner in the presence of carprofen or warfarin in dog plasma at maximum expected plasma concentrations did not reduce the protein binding of fluralaner, carprofen or warfarin.
    During clinical field testing, no interactions between Bravecto chewable tablets for dogs and routinely used veterinary medicinal products were observed.
    Mode of action Fluralaner is an inhibitor of the arthropod nervous system. It inhibits γ-aminobutyric acid (GABA)-gated chloride channels (GABAA receptors) and L-glutamate-gated chloride channels (GluCls). Potency of fluralaner is comparable to fipronil (a related GABA-antagonist insecticide and acaricide).

    Shop Tirzepatide2023788-19-2-Detailed Image 2 Shop Tirzepatide2023788-19-2-Detailed Image 3 Shop Tirzepatide2023788-19-2-Detailed Image 4 Shop Tirzepatide2023788-19-2-Detailed Image 5 Shop Tirzepatide2023788-19-2-Detailed Image 6 Shop Tirzepatide2023788-19-2-Detailed Image 7

     

    ECHEMI Editorial Reference
    Fluralaner (INN) is a systemic insecticide and acaricide that is administered orally. The U.S. Food and Drug Administration (FDA) approved it under the trade name Bravecto for flea treatment in dogs in May 2014. The EU approved the drug in February 2014. Australia approved it for the treatment and prevention of ticks and fleas on dogs in January 2015.

    Basic Info
    Product Name:

    Fluralaner

    Other Name:

    Fluralaner;A1443; AH252723;AH252723;Fluralaner-012;Fluralaner (A1443;Frellana;Fluralaner D2Q: What is Fluralaner D2 Q: What is the CAS Number of Fluralaner D2;Fluralaner D3Q: What is Fluralaner D3 Q: What is the CAS Number of Fluralaner D3

    CAS No.:

    864731-61-3

    Molecular Formula:

    C22H17Cl2F6N3O3

    InChIKeys:

    MLBZKOGAMRTSKP-UHFFFAOYSA-N

    Molecular Weight:

    556.29

    Exact Mass:

    556.29

    EC Number:

    200-001-8

    DSSTox ID:

    DTXSID90235581

    Color/Form:

    White to off-white

    ATC Code:

    QP53BE02|QP54AB52

    Characteristics
    Density:

    1.51±0.1 g/cm3(Predicted)

    PKA:

    12.50±0.46(Predicted)

    Critical Temperature & Pressure:

    Store at -20°C

    Hazard Identification

    Classification of the substance or mixture

    Hazardous to the aquatic environment, short-term (Acute) - Category Acute 1

    Hazardous to the aquatic environment, long-term (Chronic) - Category Chronic 1

    GHS label elements, including precautionary statements

    Pictogram(s)
    Signal word

    Warning

    Hazard statement(s)

    H410 Very toxic to aquatic life with long lasting effects

    Precautionary statement(s)
    Prevention

    P273 Avoid release to the environment.

    Response

    P391 Collect spillage.

    Storage

    none

    Disposal

    P501 Dispose of contents/container to an appropriate treatment and disposal facility in accordance with applicable laws and regulations, and product characteristics at time of disposal.

    Other hazards which do not result in classification

    no data available

    Handling and Storage

    Precautions for safe handling

    Handling in a well ventilated place. Wear suitable protective clothing. Avoid contact with skin and eyes. Avoid formation of dust and aerosols. Use non-sparking tools. Prevent fire caused by electrostatic discharge steam.

    Conditions for safe storage, including any incompatibilities

    Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials.

  • Seller Information
    Business Type:

    Trader

    Main Products:

    pharmaceutical intermediates,peptides,electronic chemicals

    Location:

    Room 102, 1st Floor, East Office Building, No. 45 Pengwan Road, Qianwan Bonded Port Area, Qingdao Zone, China (Shandong) Pilot Free Trade Zone

    Payment Terms:

    100% TT in advance

    Average lead Time:

    10 days

    Total Annual Revenue:

    $10 million-$25 million

    Total Employees:

    51-100

    Year of Establishment:

    2024

    A reliable supplier is like insurance.

    We are mainly specilized in supply of pharmaceutical intermediates, electronic chemicals,food additives, and other fine chemical products.
    Integrity is the foundation, quality is life. We would like to work together with you to build a greener and brighter future.

    Website: orientchem.cc
    Email: scarlett@orientchem.cc
    WhatsApp: +86 17753254221

  • Inquiry History
    35 Inquiries
    Country Product Purchase Quantity Date Posted
    Russia

    Fluralaner 98% Powder 864731-61-3 Senwayer

    100 KG Apr 13, 2026
    South Africa

    Fluralaner 98% Powder 864731-61-3 Senwayer

    2 KG Nov 1, 2023
    Mexico

    Low Price Wholesale 99% Veterinary API Fluralaner CAS 864731-61-3 white powder HHD HHD

    5 KG Oct 16, 2023
    Paraguay

    Fluralaner

    600 KG Oct 12, 2026
    Paraguay

    FLURALANER

    30 KG Oct 13, 2025
    Turkey

    fluralaner

    1 MG Jun 18, 2025
    Vietnam

    fluralaner

    50 KG Dec 11, 2024
    Ecuador

    FLURALANER

    10 KG Nov 19, 2024
    India

    fluralaner

    2 G Oct 23, 2024
    India

    Fluralaner

    1 G Oct 18, 2024
    Germany

    Fluralaner

    50 G May 11, 2024
    Brazil

    Fluralaner

    1 KG Oct 2, 2026
    Paraguay

    fluralaner

    200 KG Sep 28, 2026
    Denmark

    Fluralaner

    100 KG Sep 3, 2026
    United States

    Fluralaner

    25 MG May 26, 2026
    Paraguay

    FLURALANER

    100 KG Apr 24, 2026
    Turkey

    fluralaner

    13 G Jun 30, 2025
    Thailand

    Fluralaner

    1 KG Apr 6, 2025
    India

    Fluralaner

    2 G Jan 2, 2025
    Ecuador

    FLURALANER

    25 KG Nov 21, 2024
    • 1
    • 2
    • Go to Page Go
    Post an enquiry for this product
pic ×

Scan the QR Code to Share

All products displayed on this website are only for non-medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.

According to relevant laws and regulations and the regulations of this website, units or individuals who purchase hazardous materials should obtain valid qualifications and qualification conditions.

The information shown above is provided by the enterprise itself, and the authenticity, accuracy and legitimacy of the content are the responsibility of the publishing company. ECHEMI does not bear any guarantee responsibility for this. Please be aware that risks in internet transactions objectively exist.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.